UCA1 and pancreatic adenocarcinoma: Ultimately, m6A-LPS was established to predict the prognosis of PAAD patients based on the expression values of five lncRNAs (AC099850.3, UCA1, AP005233.2, AL513165.1, and PTOV1-AS2).